ETF Analysis
iShares U.S. Medical Devices ETF (IHI) ETF Analysis
iShares U.S. Medical Devices ETF (IHI) ETF analysis covering performance, holdings context, risk, drawdowns, volatility, momentum, dividends, valuation exposure, and the current AlgovestIQ assessment.
iShares U.S. Medical Devices ETF (IHI) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 79/100. Value is the weakest current factor at 31/100. Performance, momentum, risk, distribution, and exposure evidence should be read together at the latest market-close snapshot.
IHI at a Glance
Crawlable current metrics from the latest market-close ETF snapshot.
| Metric | Current |
|---|---|
| Price | $54.59 |
| AIQ Score | 57/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Fund Size | $3.66B |
| Expense Ratio | 0.37% |
| Holdings Count | 49 |
| NAV | $55.71 |
| Asset Class | Equity |
| Primary Exposure | Health Care Equipment (99.81%) |
| Issuer | IShares |
| Domicile | US |
| Inception Date | May 1, 2006 |
| Distribution Yield | 0.48% |
| Beta | 0.83 |
| Average Volume | 2.86M |
| 52-week range | $47.37-$64.71 |
| RSI 14 | 76.65 |
| 50-Day SMA | $53.04 |
| 200-Day SMA | $53.59 |
| Risk Score | 70/100 |
| Momentum Score | 79/100 |
| Value Exposure Score | 31/100 |
IHI Long-Horizon ETF Performance
Trailing returns, growth of $10,000, drawdown history, and calendar-year returns from available daily closes.
| Period | Total return | Annualized | Max drawdown | Start date |
|---|---|---|---|---|
| 1Y | -11.69% | -11.69% | -26.24% | Oct 28, 2025 |
| 3Y | 22.90% | 7.13% | -26.95% | Oct 30, 2023 |
| 5Y | -16.57% | -3.57% | -32.96% | Nov 1, 2021 |
| 10Y | -16.57% | -3.57% | -32.96% | Nov 1, 2021 |
Growth of $10,000
Indexed to the first available close in this history window.
Drawdown History
Peak-to-trough decline from each prior high over the available window.
Calendar-Year Returns
Full-year returns where available, with the current calendar year shown as YTD.
IHIiShares U.S. Medical Devices ETF
Financial Services / Asset Management
Low Priority
Above Peers
Latest quote
- Momentum79
- Value31
- Quality59
- Risk resilience70
- Sentiment—
IHI ETF Analysis Summary
iShares U.S. Medical Devices ETF (IHI) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 79/100. Value is the weakest current factor at 31/100. Performance, exposure, distribution, momentum, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, IHI has AIQ Score of 57/100 with Momentum base of 79/100 and fading Value at 31/100. Wait for component alignment before adding exposure.
Momentum (79/100) leads while Value (31/100) lags. This cross-factor spread creates entry timing uncertainty.
Financial Services · -1.98% ETF move · IHI classified in Asset Management.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is IHI Bullish or Bearish Right Now?
IHI currently has a neutral overall setup. Momentum is the strongest factor at 79/100, while Value is weakest at 31/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 79/100.
- - Risk Resilience is supportive at 70/100.
- - Price is +5.00% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (38 vs 6).
- - Value is the current constraint at 31/100.
Current Consensus
IHI's Technical Analysis Consensus is currently Strong Buy, with 38 buy, 1 neutral, and 6 sell votes. IHI's 14-day RSI is 76.65, which places the ETF in an overbought momentum range. IHI's beta is 0.83, indicating market sensitivity broadly in line with the market.
What Changed in IHI?
The largest recent change in IHI is Momentum moving down by 1.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the IHI Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, risk resilience improves, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, distribution or liquidity context deteriorates, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive market-context evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
IHI Decision Framework
Public evidence layers, setup checks, and risk context for iShares U.S. Medical Devices ETF.
iShares U.S. Medical Devices ETF (IHI) ETF Analysis
iShares U.S. Medical Devices ETF has an AIQ Score of 57/100 in a Neutral regime. Momentum is strongest at 79/100. Beta is 0.83, below market sensitivity. Review the supporting etf factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | IHI is in a Neutral AIQ regime with score 57/100. |
| Signal Conflict | The primary conflict is that momentum leads at 79/100 while value lags at 31/100. |
| Factor Evidence | Momentum 79/100 · Value 31/100 · Quality 59/100 · Risk 70/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 79/100.
Momentum is 79/100 and RSI (14) is 76.7.
IHI is in a Neutral regime at 57/100.
Risk factor is 70/100 with beta 0.83 and annual volatility 20.56%.
Current conflict: momentum leads at 79/100 while value lags at 31/100.
IHI Research Cluster
ETF-specific paths for performance, risk, distributions, market context, data, comparisons, and news.
IHI ETF Analytics
IHI holdings context, yield, risk, valuation exposure, momentum, and AIQ evidence.
IHI Technical Analysis
IHI technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
IHI ETF Market Context
Track IHI market context, news pressure, trend changes, income events, and current allocation evidence.
IHI Distribution Analysis
IHI distribution yield, annualized distributions, payment history, and income context.
IHI ETF Data
IHI available fund data, market metrics, technical readings, risk measures, and AIQ evidence.
IHI Risk Analysis
IHI volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
IHI ETF News
IHI ETF news, market tone, recent headlines, and catalyst context.
IHI vs Sector ETFs Peers
Current peer cohort: IHI · IYR · KBWB · KRE · SMH. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| IHI Current ETF | 57/100 | 31/100 | 79/100 | 70/100 | -0.54 | 20.56% | Current |
| IYR iShares U.S. Real Estate ETF | 58/100 | 36/100 | 68/100 | 78/100 | 0.2 | 14.09% | IHI vs IYR |
| KBWB Invesco KBW Bank ETF | 63/100 | 65/100 | 60/100 | 72/100 | 0.75 | 19.81% | IHI vs KBWB |
| KRE SPDR S&P Regional Banking ETF | 70/100 | 65/100 | 80/100 | 75/100 | 0.88 | 20.33% | IHI vs KRE |
| SMH VanEck Semiconductor ETF | 43/100 | 31/100 | 35/100 | 22/100 | 1.16 | 40.15% | IHI vs SMH |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current ETF evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of ETF evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Valuation exposure across the fund's holdings.
Quality context inferred from fund exposure and available evidence.
Trend, momentum, volume, and timing confirmation.
Resilience, volatility, beta, drawdown, and tail risk.
News and event pressure around the setup.
Open the return calculator with ETF context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalystsNo quarterly financial rows in this snapshot.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
ETF Analytics Snapshot
Current ETF evidence uses fund profile, cost, size, distribution, momentum, and risk fields.
ETF pages use fund-native profile fields for cost, size, liquidity, holdings breadth, NAV, issuer, and launch date.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching IHI
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for IHI
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
IHI ETF FAQ
What is IHI ETF price today?
IHI is currently shown at $54.59. Use the live quote with the 52-week range and AIQ context before comparing funds.
What is IHI's 52-week high and low?
IHI's 52-week range is $47.37 to $64.71 based on the latest completed market-close snapshot from Oct 30, 2026. A price near either extreme should be evaluated with volatility and trend evidence.
Does IHI pay a dividend?
IHI's current distribution yield is 0.48% based on the latest completed market-close snapshot from Oct 30, 2026. For ETFs, dividend yield should be compared with expense ratio, holdings, and risk.
What should investors compare before buying IHI?
Compare IHI's price trend, expense profile, yield, holdings exposure, volatility, and AIQ signal. ETF decisions should focus on portfolio fit as much as current momentum.